CymaBay Therapeutics Inc. (CBAY) tumbled -5.55% or -0.77 to $13.11. It is close to 675178 shares traded, which is 58.82% compare to the average total volume 1.15 million. The market cap of CBAY is $770.46 million. The year to date change is 48.67%. The 52 week price range is from $5.1 to $15.59. Price of CBAY have changed -2.46% during last week. It have changed 6.85% over last month, 6.04% over last 3 months, 39.22% over last 6 months and 155.15% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CBAY is 12.85. It is -1.98% below current price. The 200-day Moving Averages for CBAY is 11.18. It is -14.72% below current price. The 52-week High is 15.59. It is 18.92% from the current price. The 52-week Low is 5.1. It is -61.10% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CBAY is 4.43 on 2018-06-15. Short % to float is 5.86%. There are some statistics of CBAY. It is has market cap $770.46 million. The share outstanding is 58.77 million. The average volume is 1.15 million. It has 118.90M cash and 14.31M in debt. The percent of top 15 Institution holding is 77.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CBAY is -35.42%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CBAY is -30.44%.